PEX3 Gene - Peroxisome Biogenesis Factor 3

Pathway Diagram

flowchart TD
    PEX3["PEX3<br/>Peroxisome Biogenesis<br/>Factor 3"]
    
    SQSTM1["SQSTM1/p62<br/>Autophagy Receptor"]
    LC3["LC3<br/>Autophagy Marker"]
    RB1CC1["RB1CC1/FIP200<br/>Autophagy Initiation"]
    
    PARKIN["PARKIN<br/>E3 Ubiquitin Ligase"]
    SNCA["SNCA<br/>alpha-Synuclein"]
    SNCAIP["SNCAIP<br/>Synphilin-1"]
    
    MFN1["MFN1<br/>Mitofusin 1<br/>Mitochondrial Fusion"]
    BCL2["BCL2<br/>Anti-apoptotic<br/>Protein"]
    
    ERN1["ERN1/IRE1alpha<br/>ER Stress<br/>Sensor"]
    FAM134B["FAM134B<br/>ER-phagy<br/>Receptor"]
    
    ATM["ATM<br/>DNA Damage<br/>Response"]
    STING1["STING1<br/>Innate Immunity<br/>Signaling"]
    
    PD["Parkinson's<br/>Disease"]
    AD["Alzheimer's<br/>Disease"]
    ALS["Amyotrophic<br/>Lateral Sclerosis"]
    FTD["Frontotemporal<br/>Dementia"]
    
    PEX3 -->|"regulates"| SQSTM1
    SQSTM1 -->|"binds"| LC3
    PEX3 -->|"interacts"| RB1CC1
    
    PEX3 -->|"interacts"| PARKIN
    PARKIN -->|"ubiquitinates"| SNCA
    PEX3 -->|"interacts"| SNCAIP
    SNCA -->|"aggregates"| PD
    
    PEX3 -->|"regulates"| MFN1
    PEX3 -->|"interacts"| BCL2
    MFN1 -->|"maintains"| BCL2
    
    PEX3 -->|"responds_to"| ERN1
    PEX3 -->|"interacts"| FAM134B
    ERN1 -->|"activates"| FAM134B
    
    PEX3 -->|"interacts"| ATM
    PEX3 -->|"modulates"| STING1
    ATM -->|"triggers"| STING1
    
    SQSTM1 -->|"dysfunction"| AD
    PARKIN -->|"mutations"| PD
    ERN1 -->|"stress_response"| ALS
    ATM -->|"damage_response"| FTD
    
    style PEX3 fill:#006494
    style SQSTM1 fill:#4a1a6b
    style LC3 fill:#4a1a6b
    style PARKIN fill:#4a1a6b
    style BCL2 fill:#1b5e20
    style MFN1 fill:#1b5e20
    style ERN1 fill:#ef5350
    style ATM fill:#ef5350
    style PD fill:#5d4400
    style AD fill:#5d4400
    style ALS fill:#5d4400
    style FTD fill:#5d4400

Introduction

PEX3 encodes Peroxisome Biogenesis Factor 3, an essential peroxisomal membrane protein critical for peroxisome biogenesis, peroxisomal membrane protein (PMP) import, and peroxisome proliferation. PEX3 is one of the earliest factors required for peroxisome formation and serves as the primary docking site for the peroxisomal targeting signal type 2 (PTS2) receptor complex. Mutations in PEX3 cause severe peroxisome biogenesis disorders (PBDs) and are associated with impaired peroxisomal function in neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease^{1PEX3 - essential for peroxisome biogenesis2000 · Hum Genet}. ^{1PEX3 - essential for peroxisome biogenesis2000 · Hum Genet}

Overview

PEX3 is a 476-amino acid peroxisomal membrane protein that plays a central role in peroxisome biogenesis. It is evolutionarily conserved from yeast to humans and is essential for life. PEX3 functions at multiple stages of peroxisome formation:

1. Peroxisome membrane assembly: Initiates peroxisomal membrane formation

2. Membrane protein import: Docks PMP import receptors

3. Peroxisome inheritance: Facilitates peroxisome segregation during cell division

4. Organelle dynamics: Regulates peroxisome proliferation and degradation

In neurons, PEX3 is particularly important for maintaining peroxisomal function in regions with high metabolic demand and oxidative stress, making it relevant to neurodegenerative processes.

Protein Structure

Domain Organization

PEX3 contains several functional domains:

1. N-terminal cytosolic domain: Contains binding sites for PEX19 and PEX5

2. Transmembrane domains: Two hydrophobic regions anchor PEX3 in the peroxisomal membrane

3. C-terminal domain: Functions in protein-protein interactions

Structural Features

• PEX19 binding motif: PH3-like domain for PEX19 interaction

• Membrane topology: Type 3 peroxisomal membrane protein

• Oligomerization: Forms homooligomers important for function

Post-Translational Modifications

• Phosphorylation: Regulates peroxisome proliferation

• Ubiquitination: Controls PEX3 turnover

Molecular Functions

Peroxisome Biogenesis

PEX3 is essential for peroxisome formation through several mechanisms:

1. Membrane initiation: PEX3 is among the first PMPs inserted into the peroxisomal membrane

2. PEX19 partnership: PEX3 binds PEX19 (the peroxin that chaperones PMPs)

3. Receptor docking: PEX3 provides the docking site for import receptors

Import of Peroxisomal Proteins

Peroxisome Dynamics

• Proliferation: PEX3 responds to cellular signals for new peroxisome formation

• Division: Coordinates with DRP1 for peroxisome fission

• Autophagy: PEX3 regulates pexophagy (peroxisome-specific autophagy)

Brain Expression and Function

Cellular Distribution

Regional Expression

PEX3 is expressed throughout the brain with notable levels in:

• Cerebral cortex (pyramidal neurons)

• Hippocampus (CA1-CA3, dentate gyrus)

• Cerebellum (Purkinje cells)

• Substantia nigra (dopaminergic neurons)

Functions in Neural Cells

1. Lipid metabolism: Very-long-chain fatty acid oxidation

2. Redox homeostasis: Peroxisomal antioxidant enzymes (catalase, GPX1)

3. ** Plasmalogen synthesis**: Myelin phospholipids

4. Prostaglandin synthesis: Signaling molecules

Disease Associations

Zellweger Spectrum Disorders

PEX3 deficiency causes the most severe form of Zellweger syndrome^{2Peroxisome biogenesis disorders: phenotypic spectrum, pathophysiology and therapeutic approaches2015 · Orphanet J Rare Dis}:

Clinical Features:

• Severe developmental delay -Characteristic facial dysmorphism

• Hepatomegaly and liver dysfunction

• Severe neurological impairment

• Absence of peroxisomes

Genotype-Phenotype:

• Null mutations: Severe phenotype

• Missense mutations: Variable presentation

Alzheimer’s Disease

Association: Peroxisomal dysfunction in AD^{3Peroxisomal dysfunction in Alzheimer's disease2021 · J Neurosci Res}

Mechanisms:

• Reduced PEX3 expression in AD brain

• Peroxisome numbers decreased in neurons

• Impaired VLCFA metabolism

• Accumulation of very-long-chain fatty acids

• Reduced plasmalogens (myelin lipids)

Evidence:

• Post-mortem studies show decreased peroxisomes in AD brain

• PEX3 expression inversely correlates with amyloid burden

• Plasmalogen levels reduced in AD patients

Parkinson’s Disease

Association: Peroxisomal dysfunction in PD^{4Peroxisome deficiency and dysfunction in Parkinson's disease2020 · Mov Disord}

Mechanisms:

• α-Synuclein may impair peroxisome function

• PEX3 expression altered in substantia nigra

• Mitochondrial-peroxisomal cross-talk

• Lipid metabolism abnormalities

Evidence:

• Peroxisome function reduced in PD models

• PEX3 knockout mice show dopaminergic vulnerability

Other Associations

• ** Zellweger-like disorders**: Variant forms

• Autism spectrum: Some patients with PEX3 variants

• Hearing loss: Associated with peroxisomal dysfunction

Therapeutic Implications

Peroxisome-Targeted Therapies

Challenges

• Blood-brain barrier penetration

• Delivery to specific neuronal populations

• Balancing peroxisome biogenesis with potential risks

Animal Models

Knockout Mice

Pex3−/− mice:

• Embryonic lethal (required for development)

• Severe peroxisomal deficiency

• Model for Zellweger syndrome

Conditional Knockouts

Neuron-specific Pex3 knockout:

• Progressive neurodegeneration

• Behavioral deficits

• Accumulation of VLCFAs

Transgenic Models

• PEX3 overexpression: Protected against oxidative stress

• Human PEX3 mutants: Model peroxisome biogenesis disorders

Genetic Variants

Pathogenic Mutations

Polymorphisms

• Various SNPs with unknown functional significance

• Population-specific variants

Interactions and Pathways

Protein Interactions

• PEX19: Chaperone for PMP import

• PEX5: PTS1 receptor

• PEX7: PTS2 receptor

• PEX11: Peroxisome proliferation

• PEX10: Import complex component

Signaling Pathways

• PPARα signaling: Peroxisome proliferation

• Mitochondrial dynamics: Cross-talk with mitochondria

• Autophagy: Pexophagy regulation

Research Directions

1. Gene therapy: Developing AAV vectors for PEX3 delivery

2. Biomarkers: Peroxisomal function markers in CSF

3. Small molecule inducers: Compounds that enhance PEX3 expression

4. Combination therapies: Addressing multiple aspects of peroxisomal dysfunction

Unanswered Questions

1. How does PEX3 regulate peroxisome number in neurons?

2. What are the specific signals for peroxisome proliferation in the brain?

3. Can peroxisomal function be restored in degenerating neurons?

4. What is the relationship between peroxisomal and mitochondrial dysfunction?

Background

The study of Pex3 Gene Peroxisome Biogenesis Factor 3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• Peroxisome

• Peroxisome Biogenesis Disorders

• PEX2

• PEX19

• PEX1

• PEX5

• VLCFA Metabolism

• Alzheimer’s Disease

• Parkinson’s Disease

External Links

• NCBI Gene: PEX3

• UniProt: PEX3

• Ensembl: PEX3

• OMIM: PEX3